e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Invasive and noninvasive methods to assess airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The anlysis of trace elements in BAL of patients with diffuse lung diseases and Langherans cell histiocytosis
E. Bargagli, F. Monaci, P. Rottoli (Siena, Italy)
Source:
Annual Congress 2007 - Invasive and noninvasive methods to assess airway inflammation
Session:
Invasive and noninvasive methods to assess airway inflammation
Session type:
Thematic Poster Session
Number:
3478
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Bargagli, F. Monaci, P. Rottoli (Siena, Italy). The anlysis of trace elements in BAL of patients with diffuse lung diseases and Langherans cell histiocytosis. Eur Respir J 2007; 30: Suppl. 51, 3478
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Pulmonary sarcoidosis
Related content which might interest you:
Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016
The proteomic analysis of BAL from patients with langerhans cell histiocytosis (LCH)
Source: Eur Respir J 2007; 30: Suppl. 51, 245s
Year: 2007
Adult pulmonary Langerhans' cell histiocytosis
Source: Eur Respir J 2006; 27: 1272-1285
Year: 2006
Ventilation disorders dynamics and morphological changes in patients with pulmonary Langerhans cell histiocytosis (PLCH)
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Multiple cystic lung diseases
Source: Eur Respir Mon 2011; 54: 46-83
Year: 2011
Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019
An integrated approach in the diagnosis of smoking-related interstitial lung diseases
Source: Eur Respir Rev 2012 21:207-217
Year: 2012
Langerhans cell histiocytosis: is it an ILD?
Source: Virtual Congress 2021 – Interstitial lung diseases
Year: 2021
Airway dendritic cell phenotypes in inflammatory diseases of the human lung
Source: Eur Respir J 2007; 30: 878-886
Year: 2007
Smoking-related interstitial lung diseases: a concise review
Source: Eur Respir J 2001; 17: 122-132
Year: 2001
Genetic landscape of adult Langerhans cell histiocytosis with lung involvement
Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019
Year: 2020
The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Bronchoalveolar lavage cytokine profile in patients with Pulmonary Langerhans Cell Histiocytosis differs from other interstitial lung diseases
Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases
Year: 2020
A case with pulmonary histiocytosis X and lung cancer
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008
Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019
Proteomic analysis of antioxidant proteins in bronchoalveolar lavage of patients with pulmonary Langerhans-cell histiocytosis
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011
Adult pulmonary Langerhans‘ cell histiocytosis and lung cancer
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018
Clonality analysis in lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung
Source: Eur Respir J 2006; 28: Suppl. 50, 306s
Year: 2006
Pulmonary hypertension in pulmonary Langerhans’ cell histiocytosis
Source: Eur Respir Mon 2012; 57: 161-165
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept